By Joshua Kirby 
 

Siemens Healthineers AG said late Wednesday that its Covid-19 rapid self-test has been cleared for use in the U.S. and should be available there beginning next month.

The German medical-equipment maker said its nasal antigen Clinitest was granted emergency-use authorization by the U.S. Food and Drug Administration.

The test, which can be bought over the counter and self-administered, should be available beginning in January, with production capacity for the U.S. market reaching tens of millions of tests monthly, Siemens Healthineers said.

 

Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby

 

(END) Dow Jones Newswires

December 30, 2021 03:39 ET (08:39 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Siemens Healthineers (XE:SHL)
Historical Stock Chart
Von Sep 2022 bis Okt 2022 Click Here for more Siemens Healthineers Charts.
Siemens Healthineers (XE:SHL)
Historical Stock Chart
Von Okt 2021 bis Okt 2022 Click Here for more Siemens Healthineers Charts.